Trusted Data.
Transformative Outcomes.
AI only delivers when it's built on validated historical clinical data, shaped by 25+ years of clinical expertise, and embedded in a platform that spans the full clinical trial lifecycle.
Our AI is in every protocol, process, workflow, and trial to accelerate your next breakthrough treatment. That's AI for Impact.
AI Built for Your Clinical Reality
Our AI is purpose-built for clinical trials so they start and stay on track. By simulating outcomes, surfacing insights early, and guiding next best actions your teams can move forward with confidence.
Medidata AI Is Different.
Embedded throughout our unified architecture, Dot is trained on validated data from 38,000 trials and 12 million patients.
It doesn’t just analyze, it acts.
No matter your indication, patient cohort, or geography, it simulates outcomes, proactively surfaces risks, and recommends next-best actions—delivering tailored, data-backed guidance that keeps your trials on track and ahead of disruption.
PATIENT & SITE ENGAGEMENT
Less Burden, Better Experience
Give your patients and sites a seamless, low-burden experience. Built with direct patient input, our intuitive tools and streamlined workflows reduce friction across every phase of your study.
Deliver a patient journey that sustains engagement and supports participants, from first visit through final follow-up.
Data Management & Oversight
Unify Disparate Data Sources
Automatically configure systems and edit checks to accelerate start-up by weeks.
Our AI, aggregates and standardizes trial data, elevates quality, compresses review cycles, and delivers real-time insights that proactively reduce risk.
Study Design & Execution
Accelerate Study Start with Confidence
Remove weeks from planning and replace guesswork with precision.
Dot optimizes protocols for feasibility, surfacing enrollment, budget, burden, and safety risks early so you can adapt quickly, avoid delays, and keep trials on track.
The Impact of Medidata AI
Make Better Decisions
Make Better Decisions, Early
Optimize protocols, reduce patient burden, validate site feasibility, and safeguard trial safety while your study is live. Monitor engagement, data quality, and operational performance in real time.
AI surfaces trial risk early and recommends next best actions so you can intervene before issues become amendments, delays, or rework
Featured Resource
AI Is Reshaping MedTech Trials. Here’s How.
By applying AI to both products and processes, MedTech leaders are reshaping study design, execution, and scale.
Download Report
Industry Insights
The State of AI in Clinical Trials:
Today and Tomorrow
A grounded look at how AI is being applied in regulated clinical research today, and what it takes to scale AI responsibly across development programs.
Report: Everest Group 2026 Innovation Watch: AI in Clinical Trials
Get exclusive access to Everest Group’s assessment of 18 clinical AI providers to see which companies and capabilities are driving the future of clinical trials.
Blog: The Efficiencies of AI for Clinical Trial Sponsors
Learn how clinical trial sponsors are seeing new efficiencies from the use of AI across the entire trial experience—from study design to feasibility and site selection.
Blog: Clinical Trial Planning: How AI Is Transforming the Process
Read how clinical trial planning is notably complex—and how AI is transforming the process with insights that can proactively de-risk trials before they begin.
Blog: How Clinical Trials Can Maximize Generative AI Investments
Explore how those who invest now in embedding adaptive, workflow-driven AI can accelerate clinical trial timelines, reduce risk, and deliver stronger outcomes.
FAQ
What is Medidata AI?
Medidata AI is purpose-built for clinical trials, not retrofitted or off the shelf. It is trained on validated data from 38,000 trials, 12 million patients, and 70B data points per year. Embedded throughout a unified platform that spans the full trial lifecycle, Medidata AI connects every stage of your trial, ensuring seamless handoffs and eliminating costly rework that often leads to errors. It doesn't just analyze, it simulates outcomes and recommends best actions, making your trial predictive, not reactive.
What is Dot?
Dot is a visual representation of AI within the Medidata Platform. It signals intelligence and interactivity in our offerings.
How is Medidata AI different from other clinical AI solutions?
Purpose-built for clinical trials, Medidata AI is trained on validated data from 38,000 trials and 12 million patients. Embedded across a unified architecture, it doesn’t just analyze—it simulates outcomes and recommends next best actions, making your trial predictive, not reactive. Insights is produced in context and applied within a study and across development programs, not reset trial by trial.
Related resource:
Report: The State of AI in Clinical Trials: Today and Tomorrow
How does Medidata AI support trust, governance, and auditability?
Models are developed and validated by scientists, physicians, technologists, and former regulatory leaders. Outputs are explainable and auditable, and applied within controlled workflows designed for regulated research. Medidata applies security and privacy practices to anonymize and protect patient data and support patient safety, without increasing operational or compliance risk.
Learn more about Medidata’s unified approach
to trust, security, and transparency.
What data is Medidata AI built on?
Medidata AI is built on decades of structured clinical trial data captured within the Medidata Platform—spanning phases, therapeutic areas, geographies, and operational models.
Because the data originates inside regulated workflows, it is standardized, permissioned, and traceable. That foundation, combined with embedded governance and validated systems, enables AI insights that are contextual, auditable, and ready for use in real-world trial operations.